Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C

Direct-acting antivirals (DAA) are highly effective for the treatment of hepatitis C (HCV), although there are limited data on the safety and efficacy of DAA therapy in hepatitis C-positive individuals awaiting liver transplantation for hepatocellular carcinoma (HCC). METHODS: We conducted a retrosp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplant Direct
Main Authors: Tse, Chung Sang, Yang, Ju Dong, Mousa, Omar Y., Nelson, Kevin M., Pungpapong, Surakit, Keaveny, Andrew, Aqel, Bashar A., Vargas, Hugo, Dickson, Rolland C., Watt, Kymberly, Gores, Gregory J., Roberts, Lewis R., Leise, Michael D.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Liver Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7725260/
https://ncbi.nlm.nih.gov/pubmed/33324740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001049
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados